Published online before print November 3, 2008, doi: 10.1161/HYPERTENSIONAHA.108.121582
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2008;52:1134.)
© 2008 American Heart Association, Inc.
Original Articles |
Dietary Salt Activates an Endothelial Proline-Rich Tyrosine Kinase 2/c-Src/Phosphatidylinositol 3-Kinase Complex to Promote Endothelial Nitric Oxide Synthase Phosphorylation
From the Division of Nephrology (W.-Z.Y., K.A., P.W.S.), Department of Medicine, and Department of Physiology and Biophysics (P.W.S.), University of Alabama at Birmingham; and the Department of Veterans’ Affairs Medical Center (P.W.S.), Birmingham, Ala.
Correspondence to Paul W. Sanders, Division of Nephrology/Department of Medicine, 642 Lyons-Harrison Research Building, 1530 Third Ave, S, University of Alabama at Birmingham, Birmingham, AL 35294-0007. E-mail psanders{at}uab.edu
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
Although many laboratories have shown that dietary NaCl (salt) intake increases NO production in rodents and humans, the mechanism has not been uncovered. In the present study, pharmacological and dominant-negative strategies were used to show that feeding a formulated diet containing increased amounts of salt to young male Sprague-Dawley rats induced the formation of an endothelial cell-signaling complex that contained proline-rich tyrosine kinase 2, c-Src (also known as pp60c-src), and phosphatidylinositol 3-kinase. In the setting of a high-salt diet, proline-rich tyrosine kinase 2 served as the scaffold for c-Src–mediated phosphatidylinositol 3-kinase activation. Phosphatidylinositol 3-kinase was the upstream activator of protein kinase B (Akt), which was responsible for phosphorylation of the rat endothelial isoform of NO synthase at S1176 and thereby promoted the increase in NO production. The combined findings illustrated the crucial role for a proline-rich tyrosine kinase 2–signaling complex in the endothelial response to salt intake.
Key Words: NO • cell signaling • cell biology • animal models of human disease
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Following the original description of the role of NO1 in the blood pressure responses to changes in dietary NaCl (termed "salt" in this article) intake,1 subsequent studies confirmed that increased salt intake increased NO production in rodents2–5 and healthy humans.6 NO plays an important role in the hemodynamic response to changes in salt intake. Salt-induced NO release promotes vasorelaxation of the afferent arteriole,7 augments the glomerular filtration rate,8 and improves the pressure-natriuresis curve, facilitating salt excretion.9 Inhibition of NO results in salt retention and salt-sensitive hypertension10 and, if protracted, leads to renal injury, particularly if the animals are maintained on a high-salt diet.11
The direct involvement of the endothelium in mediating NO production in response to a high-salt diet has been demonstrated.12 The mechanism by which salt intake increases endothelial NO production appears to be initiated through generation of shear forces.13–15 The endothelial isoform of NO synthase, termed "NOS3" in this article, is a highly regulated enzyme that is controlled by a variety of posttranslational events that include phosphorylation of multiple serine and threonine residues of NOS3. Although NOS3 enzyme activity depends on binding of a calcium/calmodulin complex to NOS3, displacing an autoinhibitory loop and activating function, several laboratories have shown that shear stress also promotes a calcium-independent activation of NOS3.16,17 The present view is that calcium/calmodulin activation of NOS3 is responsible only for transient increases in NO, whereas other posttranslational events provide more prolonged NO release from NOS3.18,19 In particular, NOS3 can serve as a substrate for protein kinase B (Akt), which promotes serine phosphorylation at residue 1176 in the carboxyl terminal portion of NOS3 and increases NOS3 sensitivity to calcium/calmodulin and enzyme activity.20
Recent studies show that dietary salt intake activates proline-rich tyrosine kinase 2 (Pyk2).21 Pyk2 (also designated FAK2, CAK-ß, CADTK, or RAFTK) is a member of the focal adhesion protein tyrosine kinase family.22 This nonreceptor tyrosine kinase is typically activated by extracellular stress signals, such as shear stress,23 but also by G protein–coupled receptors, such as the angiotensin type 1 receptor.22,24 Pyk2 has multiple binding partners that include c-Src, the 60-kDa protein of c-src (also known as pp60c-src), phosphatidylinositol 3-kinase (PI3-kinase), and Grb2.22,25–27 Binding to Pyk2 activates c-Src and PI3-kinase, and this signaling complex participates in a variety of intracellular processes.22,28 Because PI3-kinase is an upstream activator of Akt, the present study has, therefore, been designed to determine whether an increase in the phosphorylation state of S1176 of NOS3 accounts for the augmented endothelial NO production that occurs in the setting of increased salt intake and whether dietary salt intake induces a Pyk2/c-Src/PI3-kinase complex that, in turn, increases NOS3 activity through activation of Akt.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Animal and Tissue Preparation
The institutional animal care and use committee at the University of Alabama at Birmingham approved the project. Studies were conducted using male Sprague-Dawley rats (Harlan Sprague Dawley, Indianapolis, Ind) that were 28 days of age at the start of study. The protocol that was followed has been standardized in our laboratory.13,14,29 The rats were housed under standard conditions and given formulated diets (AIN-76A, Dyets, Inc) that contained 0.3% and 8.0% (wt/wt) NaCl. These nitrite- and nitrate-free diets were prepared specifically to be identical in protein composition and differed only in NaCl and sucrose content. On the fourth day of the study, the rats were anesthetized by intraperitoneal injection of pentobarbital sodium injection (Ovation Pharmaceuticals, Inc), 50 mg/kg body weight, and aorta and isolated glomeruli were obtained under sterile conditions for incubation studies and immunoblot analyses as performed previously.13–15,29–31 The primary antibodies were diluted 1:1000 and recognized specifically the 20– to 30–amino acid sequence around the phosphorylated serine residue at position 1177 in human NOS3 (Cell Signaling Technology), p-Akt(S473), p-Akt(T308), total Akt (Cell Signaling Technology), and GAPDH (Abcam, Inc). Because analysis of the published cDNA sequence of rat NOS3 (accession No. NM_021838) showed that the serine residue that corresponded to S1177 in the human NOS3 sequence and S1179 in the bovine sequence was amino acid residue 1176, phosphorylation of this serine residue is referred to as "p-NOS3(S1176)" in this article.
In Vitro Incubation Studies
After removal of adherent fat and connective tissue, that aorta was cut into 3-mm ring segments and placed in 48-well plates. Isolated glomeruli (5x103 glomeruli per milliliter), which were obtained by sieving renal cortical tissue, and aorta ring preparations were washed with cold PBS. Pelleted glomeruli and aortic ring segments were resuspended in serum-free medium (DMEM; Invitrogen Corporation) that contained vehicle alone, 5 µmol/L of tyrphostin A9 (EMD Biosciences, Inc), or 10 µmol/L of PP2 (EMD Biosciences, Inc). Tyrphostin A9 served as an inhibitor of Pyk2,32 and PP2, 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine), was a potent, cell-permeable, Src family selective tyrosine kinase inhibitor.33
Studies In Vivo
To characterize the interactions further, peptide fragments of Pyk2 were designed to interfere with specific interactions between Pyk2 and potential binding partners. Transduction of these peptides was accomplished through the generation of fusion proteins that consisted of the peptide segments of Pyk2 and the minimal transduction domain of HIV, termed "Tat."34 The constructs in the pTatHA bacterial expression vector were generous gifts from Dr Carl Nathan (Weill Medical College, Cornell University, Ithaca, NY). Tat-AP was a fusion protein that consisted of the Tat peptide fused to a portion of the kinase domain of Pyk2 and contained the recognition domain for the SH2 group of c-Src. Tat-PBM consisted of the Tat peptide fused to amino acid residues 581 to 700 of the kinase domain of Pyk2 and included the purported binding site (YTLM) for the SH2 domain of PI3-kinase. Tat-GBM consisted of the Tat peptide fused to a peptide fragment that corresponded with a carboxyl terminal portion of Pyk2 and contained the Grb2-binding motif. These Tat fusion proteins, which served as cell-permeant, site-specific, dominant-negative inhibitors of Pyk2 interaction and activation, have been used by this laboratory to determine that dietary salt intake promoted interaction between Pyk2 and c-Src in vitro and in vivo.21
On the third day on either the 0.3% or 8.0% NaCl diet, rats received a single intravenous bolus of 0.5 mL of PBS that contained vehicle alone; 50 nmol of LY294002; a PI3-kinase inhibitor that is efficacious in vivo35,36; or 1.25 nmol of Tat-AP, Tat-GBM, or Tat-PBM. The following day, the rats were anesthetized, and aortic tissue and glomeruli were obtained to generate tissue lysates for Western blotting and immunoprecipitation experiments or for in vitro incubation studies. At the time of tissue harvesting, urine was collected from the bladder to determine NO metabolites (NOx), which were assayed using a kit (QuantiChrom Nitric Oxide Assay kit, BioAssay Systems), and creatinine concentration, which was assayed using an autoanalyzer (Creatinine Analyzer 2, Beckman Coulter, Inc). In these studies, assays were performed in triplicate and averaged; NOx values were normalized using the creatinine concentration obtained in each sample. Isolated glomeruli and aortic ring segments were incubated in serum-free medium (DMEM; Invitrogen Corporation) at 37°C for 24 hours. The conditioned medium was harvested, centrifuged at 300g for 10 minutes at 4°C to remove cell debris, and then stored at –80°C until assayed for NOx; the results were factored by wet weight (for aortic tissue) or total protein (for glomeruli).
Coimmunoprecipitation Assays
Coimmunoprecipitation studies were performed to characterize the effect of dietary salt intake on the interactions between Pyk2 and PI3-kinase. Tissue lysates containing 500 µg of total protein were obtained from the rats used in the in vivo studies and were incubated with 2 µg of an anti-Pyk2 polyclonal antibody (Cell Signaling) at 4°C for 2 hours, followed by the addition of 30 µL of protein A-Sepharose and incubation. Immune pellets were washed 3 times with ice-cold radioimmunoprecipitation assay buffer and then boiled in SDS sample buffer containing dithiothreitol. The proteins were resolved on 7.5% SDS-polyacrylamide gels and transferred to polyvinylidene fluoride membranes. The membranes were probed with antibodies directed against 4 isoforms of the catalytic unit of PI3-kinase (p110
, p110β, p110
, and p110
) and the regulatory subunit p85 (Upstate Chemicon). Immunoreactive bands were visualized with the use of enhanced chemiluminescence.
Statistical Analysis
Data were expressed as means±SEs. Significant differences among data sets were determined by ANOVA with posthoc testing (Fisher’s protected least-significant difference; Statview 5.0, SAS Institute, Inc). P<0.05 assigned statistical significance.
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Dietary Salt Intake Increased NOS3 Phosphorylation Through an Akt-Dependent Mechanism
After 4 days on the 2 diets, lysates from aortic tissue and isolated glomeruli were obtained from the rats (n=6 in each group), and phosphorylation of NOS3 at S1176 was determined using an antibody that specifically recognized p-NOS3(S1176). Compared with samples from rats on the 0.3% NaCl diet, lysates from aorta and isolated glomeruli of rats on the 8.0% NaCl diet contained increased (P<0.05) amounts of p-NOS3(S1176), which was expressed as the ratio of the density of phosphorylated NOS3 and GAPDH in each sample (Figure 1A). When incubated in medium, aortic rings and isolated glomeruli from rats on the 8.0% NaCl diet produced increased amounts of NOx compared with samples from rats on the 0.3% NaCl diet. Mechanical removal of the endothelium reduced NOx production in both groups to levels that did not differ (Figure 1B). To determine whether PI3-kinase was involved in salt-induced phosphorylation of NOS3, on the day before study, rats on both diets received an intravenous bolus of LY294002 (Figure 2). Administration of LY294002 reduced p-NOS3(S1176) levels in both aorta and glomeruli to those seen in corresponding samples obtained from rats on the 0.3% NaCl diet.
|
|
Activation of NOS3 by Dietary Salt Occurred Through a Pyk2/c-Src/PI3-Kinase–Dependent Mechanism
Previous studies showed that dietary salt induced the phosphorylation and activation of an endothelial Pyk2/c-Src complex.21 To test whether these enzymes were also involved in NO production during increased salt ingestion, in initial experiments, tissue samples from rats on both diets were incubated in medium that contained tyrphostin A9, a Pyk2 inhibitor,32 and PP2, a c-Src inhibitor,33 and NOx release into the medium was quantified. Both inhibitors decreased NOx production by aortic segments and by isolated glomeruli (Figure 3). A dominant-negative approach was then used to determine whether Pyk2 was involved directly in Akt activation. On the day before study, 1.25 nmol of Tat-AP, Tat-PBM, and Tat-GBM proteins were administered IV to groups of rats on both diets (Figure 4). Although Tat-GBM did not alter the phosphorylation state of Akt at T308 and S473 in aortic and glomerular lysates from rats on the 8.0% NaCl diet, both Tat-AP and Tat-PBM decreased (P<0.05) relative levels of p-Akt(T308) and p-Akt(S473) compared with corresponding samples from animals that received the 8.0% NaCl diet and intravenous bolus of vehicle alone. None of the 3 Tat fusion proteins produced a significant effect on Akt phosphorylation at either amino acid residue in samples obtained from rats on the 0.3% NaCl diet. Initial coimmunoprecipitation experiments determined that the p110 isoform and not the p110ß, p110, and p110 isoforms served as the p85 partner in binding Pyk2 (data not shown). Intravenous administration of Tat-AP and Tat-PBM, but not Tat-GBM, resulted in diminished binding of p85 and p110 to Pyk2 in lysates from tissues obtained from rats on the 8.0% NaCl diet (Figure 5). Preadministration of the Tat fusion proteins produced no demonstrable effect on the binding of p85 and p110 to Pyk2 in lysates from tissues obtained from rats on the 0.3% NaCl diet. Together with previous studies,21 the combined experiments showed that Tat-AP and Tat-PBM disrupted a Pyk2/c-Src/PI3-kinase signaling complex that activated Akt. In other studies, both Tat-AP and Tat-PBM, but not Tat-GBM, also diminished relative levels of p-NOS3(S1176) in tissues from rats on the 8.0% NaCl diet (Figure 6). When aortic rings and isolated glomeruli from rats on the 8.0% NaCl diet were incubated in vitro, release of NOx into the medium was diminished by the preadministration of Tat-AP and Tat-PBM, but not Tat-GBM, to levels observed in corresponding samples from rats on the 0.3% NaCl diet (Figure 7). Urinary NOx:creatinine ratios obtained the morning of the experiment showed the expected increase in urinary NOx in the groups of rats on the 8.0% NaCl diet compared with the group of rats on the 0.3% NaCl diet (Figure 8). The parenteral administration of Tat-AP and Tat-PBM reduced urinary NOx:creatinine to levels that did not differ from that observed in the group of rats that were maintained on the 0.3% NaCl diet and received vehicle treatment alone.
|
|
|
|
|
|
P>0.05 vs the group that received the 0.3% NaCl diet and vehicle (Veh). |
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
The current series of experiments used 2 different vascular tissues to confirm that endothelial NO production increased as dietary salt intake increased; the mechanism of this increase has now been clarified. Recent observations from this laboratory demonstrated a dose-dependent effect of salt intake on activation of endothelial Pyk2, which recruited and activated c-Src.21 Novel findings of the present study include the observation that dietary salt intake induced an intracellular signaling complex that not only contained Pyk2 and c-Src but also p85 and p110
; this complex was directly involved in the activation of Akt that, in turn, produced the posttranslational modification that increased NOS3 production of NO in the setting of a high-salt diet. By adding to the elegant studies of Matsui et al,37 who showed that Pyk2 is involved in modulating NOS3 activity in angiogenesis and ischemia, the data further supported an integral role for Pyk2 in signal transduction events that regulate NOS3 function in normal and disease states. The present study is also not at variance with the recent findings of Fisslthaler et al,38 who overexpressed Pyk2 to demonstrate that, in the setting of shear stress, Pyk2 can associate directly with NOS3 and promote the phosphorylation of Y657, which serves as an inhibitor of enzyme function and mitigates but does not prevent shear-induced augmentation of NO production. The variety of posttranslational events that alter NOS3 activity has been reviewed.19,39 Serine phosphorylation of amino acid residue 1176 in the carboxyl terminal portion of NOS3 is a particularly important regulator of enzyme activity and sensitivity to calcium/calmodulin activation.20 Other than Akt, AMP kinase, protein kinase A, protein kinase G, and calcium/calmodulin–dependent protein kinase II have been implicated in the regulation of the state of phosphorylation of NOS3 at 1176.19,39 The evidence for the selective involvement of Akt in salt-mediated phosphorylation of NOS3 included the demonstration that Akt activation and NOS3 phosphorylation were prevented by the inhibition of recruitment and activation of PI3-kinase by Pyk2 after an increase in dietary salt intake, and LY294002 decreased p-NOS3(S1176) levels in animals receiving the 8.0% NaCl diet to those observed in rats on the 0.3% NaCl diet. Because the latter observation suggested that phosphorylation at 1176 was sufficient to explain the increase in NO production, other posttranslational modifications of NOS3, such as tyrosine phosphorylation of NOS3 at T83, which also increases NOS3 activity and occurs through c-Src,40 were not explored.
The data demonstrating increased phosphorylation of NOS3 at S1176 in glomeruli conflicted with the findings of Mount et al,5 who also showed that NOx production increased as dietary salt increased but did not demonstrate an increase in S1176 phosphorylation in kidney lysates. Their novel method for quantifying NOS3 initially used precipitation from whole-kidney lysates using 2',5'-ADP Sepharose; aside from technical concerns related to this technique, their approach of using kidney lysates potentially obscured changes in regional or local expression of p-NOS3.
By permitting the intracellular delivery of our protein inhibitors without viral vectors,41,42 the use of Tat fusion proteins enabled additional testing of the hypothesis in the in vivo condition.21 The Tat fusion proteins (Tat-AP, Tat-PBM, and Tat-GBM) were designed to interfere specifically with binding of Pyk2 to c-Src, p85, and Grb2, respectively. Several laboratories independently demonstrated the efficacy of these inhibitors.21,43,44 Addition of both Tat-AP and Tat-PBM inhibited binding of p85 and p110 to Pyk2 and subsequent activation of Akt and phosphorylation of NOS3. One interpretation of these data is that binding of c-Src to Pyk2, which occurs through the SH3 domain on c-Src,45,46 was essential for binding to Pyk2 and activation of PI3-kinase. The data were consistent with the findings of Taniyama et al,28 who demonstrated that activated Pyk2 served as a scaffold to promote c-Src-dependent PI3-kinase activation. The data generated using Tat-GBM showed that there was no role for Grb2 in dietary salt-induced NO production and further permitted use of Tat-GBM as an additional control for the Tat fusion protein experiments.
Perspectives
In summary, the present series of experiments demonstrated that dietary salt intake directly promoted a complex endothelial cell-signaling cascade that induced Akt-mediated phosphorylation of NOS3 at S1176 and augmented NO production. It is relevant that salt-mediated vascular production of transforming growth factor-ß1 also occurs through a Pyk2-dependent process involving c-Src,21 and NO is an important compensatory response that mitigates the effects of transforming growth factor-ß1.31 Pyk2, therefore, becomes a key signaling molecule in the vascular response to dietary salt intake. Although in the present study vascular reactivity was not examined, Atochin et al47 demonstrated the in vivo relevance of this posttranslational modification by showing that transgenic mice expressing NOS3 possessing a S1179D (phosphomimetic) mutation had increased vascular reactivity when compared with transgenic mice expressing NOS3 possessing an S1179A mutation. Although these findings suggest physiological benefit, in conditions that induce oxidative stress in the vessel wall, NOS3 can produce superoxide rather than NO, and phosphorylation of human NOS3 at S1177 is also pivotal in the regulation of superoxide production.48 Although the present findings were limited to rats, elucidating the mechanism of dietary salt-induced alterations in NOS3 function permits improved understanding of the nature of the interaction between the endothelium and dietary salt intake in physiological and pathological states that alter NO production, such as diabetes mellitus, hypertension, and aging.
|
Acknowledgments |
|---|
Sources of Funding
A National Institutes of Health grant (R01 DK46199) and the Office of Research and Development, Medical Research Service, Department of Veterans’ Affairs, supported this research.
Disclosures
None.
Received August 15, 2008; first decision September 7, 2008; accepted September 30, 2008.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
1. Chen PY, Sanders PW. L-arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J Clin Invest. 1991; 88: 1559–1567.[Medline] [Order article via Infotrieve]
2. Chen PY, Sanders PW. Role of nitric oxide synthesis in salt-sensitive hypertension in Dahl/Rapp rats. Hypertension. 1993; 22: 812–818.
3. Deng X, Welch WJ, Wilcox CS. Renal vasoconstriction during inhibition of NO synthase: effects of dietary salt. Kidney Int. 1994; 46: 639–646.[Medline] [Order article via Infotrieve]
4. Shultz PJ, Tolins JP. Adaptation to increased dietary salt intake in the rat: role of endogenous nitric oxide. J Clin Invest. 1993; 91: 642–650.[Medline] [Order article via Infotrieve]
5. Mount PF, Fraser SA, Watanabe Y, Lane N, Katsis F, Chen ZP, Kemp BE, Power DA. Phosphorylation of neuronal and endothelial nitric oxide synthase in the kidney with high and low salt diets. Nephron Physiol. 2005; 102: 36–50.
6. Bech JN, Nielsen CB, Ivarsen P, Jensen KT, Pedersen EB. Dietary sodium affects systemic and renal hemodynamic response to NO inhibition in healthy humans. Am J Physiol. 1998; 274 (5 pt 2): F914–F923.[Medline] [Order article via Infotrieve]
7. Juncos LA, Garvin J, Carretero OA, Ito S. Flow modulates myogenic responses in isolated microperfused rabbit afferent arterioles via endothelium-derived nitric oxide. J Clin Invest. 1995; 95: 2741–2748.[Medline] [Order article via Infotrieve]
8. Deng A, Baylis C. Locally produced EDRF controls preglomerular resistance and ultrafiltration coefficient. Am J Physiol. 1993; 264 (2 pt 2): F212–F215.[Medline] [Order article via Infotrieve]
9. Patel A, Layne S, Watts D, Kirchner KA. L-Arginine administration normalizes pressure natriuresis in the hypertensive Dahl rats. Hypertension. 1993; 22: 863–869.
10. Tolins JP, Shultz PJ. Endogenous nitric oxide synthesis determines sensitivity to the pressor effect of salt. Kidney Int. 1994; 46: 230–236.[Medline] [Order article via Infotrieve]
11. Fujihara CK, Michellazzo SM, De Nucci G, Zatz R. Sodium excess aggravates hypertension and renal parenchymal injury in rats with chronic NO inhibition. Am J Physiol. 1994; 266 (5 pt 2): F697–F705.[Medline] [Order article via Infotrieve]
12. Ying W-Z, Sanders PW. Dietary salt increases endothelial nitric oxide synthase and TGF-ß1 in rat aortic endothelium. Am J Physiol. 1999; 277 (4 pt 2): H1293–H1298.[Medline] [Order article via Infotrieve]
13. Ying W-Z, Sanders PW. Dietary salt modulates renal production of transforming growth factor-ß in rats. Am J Physiol. 1998; 274 (4 pt 2): F635–F641.[Medline] [Order article via Infotrieve]
14. Ying W-Z, Sanders PW. Dietary salt increases endothelial nitric oxide synthase and TGF-ß1 in rat aortic endothelium. Am J Physiol. 1999; 277 (4 pt 2): H1293–H1298.[Medline] [Order article via Infotrieve]
15. Ying W-Z, Sanders PW. Increased dietary salt activates rat aortic endothelium. Hypertension. 2002; 39: 239–244.
16. Corson MA, James NL, Latta SE, Nerem RM, Berk BC, Harrison DG. Phosphorylation of endothelial nitric oxide synthase in response to fluid shear stress. Circ Res. 1996; 79: 984–991.
17. Fleming I, Bauersachs J, Fisslthaler B, Busse R. Ca2+-independent activation of the endothelial nitric oxide synthase in response to tyrosine phosphatase inhibitors and fluid shear stress. Circ Res. 1998; 82: 686–695.
18. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, Sessa WC. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature. 1999; 399: 597–601.[CrossRef][Medline] [Order article via Infotrieve]
19. Fulton D, Gratton JP, Sessa WC. Post-translational control of endothelial nitric oxide synthase: why isn’t calcium/calmodulin enough? J Pharmacol Exp Ther. 2001; 299: 818–824.
20. Lane P, Gross SS. Disabling a C-terminal autoinhibitory control element in endothelial nitric-oxide synthase by phosphorylation provides a molecular explanation for activation of vascular NO synthesis by diverse physiological stimuli. J Biol Chem. 2002; 277: 19087–19094.
21. Ying WZ, Aaron K, Sanders PW. Mechanism of dietary salt-mediated increase in intravascular production of TGF-ß1. Am J Physiol Renal Physiol. 2008; 295: F406–F414.
22. Avraham H, Park SY, Schinkmann K, Avraham S. RAFTK/Pyk2-mediated cellular signalling. Cell Signal. 2000; 12: 123–133.[CrossRef][Medline] [Order article via Infotrieve]
23. Tai LK, Okuda M, Abe J, Yan C, Berk BC. Fluid shear stress activates proline-rich tyrosine kinase via reactive oxygen species-dependent pathway. Arterioscler Thromb Vasc Biol. 2002; 22: 1790–1796.
24. Hunyady L, Catt KJ. Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. Mol Endocrinol. 2006; 20: 953–970.
25. Lev S, Moreno H, Martinez R, Canoll P, Peles E, Musacchio JM, Plowman GD, Rudy B, Schlessinger J. Protein tyrosine kinase PYK2 involved in Ca(2+)-induced regulation of ion channel and MAP kinase functions. Nature. 1995; 376: 737–745.[CrossRef][Medline] [Order article via Infotrieve]
26. Avraham S, London R, Fu Y, Ota S, Hiregowdara D, Li J, Jiang S, Pasztor LM, White RA, Groopman JE, Avraham H. Identification and characterization of a novel related adhesion focal tyrosine kinase (RAFTK) from megakaryocytes and brain. J Biol Chem. 1995; 270: 27742–27751.
27. Davies PF. Multiple signaling pathways in flow-mediated endothelial mechanotransduction: PYK-ing the right location. Arterioscler Thromb Vasc Biol. 2002; 22: 1755–1757.
28. Taniyama Y, Weber DS, Rocic P, Hilenski L, Akers ML, Park J, Hemmings BA, Alexander RW, Griendling KK. Pyk2- and Src-dependent tyrosine phosphorylation of PDK1 regulates focal adhesions. Mol Cell Biol. 2003; 23: 8019–8029.
29. Ying W-Z, Sanders PW. Dietary salt enhances glomerular endothelial nitric oxide synthase through TGF-ß1. Am J Physiol. 1998; 275 (1 pt 2): F18–F24.[Medline] [Order article via Infotrieve]
30. Ying W-Z, Sanders PW. Dietary salt intake activates MAP kinases in the rat kidney. FASEB J. 2002; 16: 1683–1684.
31. Ying W-Z, Sanders PW. The interrelationship between TGF-ß1 and nitric oxide is altered in salt-sensitive hypertension. Am J Physiol Renal Physiol. 2003; 285: F902–F908.
32. Fuortes M, Melchior M, Han H, Lyon GJ, Nathan C. Role of the tyrosine kinase pyk2 in the integrin-dependent activation of human neutrophils by TNF. J Clin Invest. 1999; 104: 327–335.[Medline] [Order article via Infotrieve]
33. Hanke JH, Gardner JP, Dow RL, Changelian PS, Brissette WH, Weringer EJ, Pollok BA, Connelly PA. Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J Biol Chem. 1996; 271: 695–701.
34. Becker-Hapak M, McAllister SS, Dowdy SF. TAT-mediated protein transduction into mammalian cells. Methods. 2001; 24: 247–256.[CrossRef][Medline] [Order article via Infotrieve]
35. Vlahos CJ, Matter WF, Hui KY, Brown RF. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem. 1994; 269: 5241–5248.
36. Su JD, Mayo LD, Donner DB, Durden DL. PTEN and phosphatidylinositol 3'-kinase inhibitors up-regulate p53 and block tumor-induced angiogenesis: evidence for an effect on the tumor and endothelial compartment. Cancer Res. 2003; 63: 3585–3592.
37. Matsui A, Okigaki M, Amano K, Adachi Y, Jin D, Takai S, Yamashita T, Kawashima S, Kurihara T, Miyazaki M, Tateishi K, Matsunaga S, Katsume A, Honshou S, Takahashi T, Matoba S, Kusaba T, Tatsumi T, Matsubara H. Central role of calcium-dependent tyrosine kinase PYK2 in endothelial nitric oxide synthase-mediated angiogenic response and vascular function. Circulation. 2007; 116: 1041–1051.
38. Fisslthaler B, Loot AE, Mohamed A, Busse R, Fleming I. Inhibition of endothelial nitric oxide synthase activity by proline-rich tyrosine kinase 2 in response to fluid shear stress and insulin. Circ Res. 2008; 102: 1520–1528.
39. Mount PF, Kemp BE, Power DA. Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation. J Mol Cell Cardiol. 2007; 42: 271–279.[CrossRef][Medline] [Order article via Infotrieve]
40. Fulton D, Church JE, Ruan L, Li C, Sood SG, Kemp BE, Jennings IG, Venema RC. Src kinase activates endothelial nitric-oxide synthase by phosphorylating Tyr-83. J Biol Chem. 2005; 280: 35943–35952.
41. Gump JM, Dowdy SF. TAT transduction: the molecular mechanism and therapeutic prospects. Trends Mol Med. 2007; 13: 443–448.[Medline] [Order article via Infotrieve]
42. Joliot A, Prochiantz A. Transduction peptides: from technology to physiology. Nat Cell Biol. 2004; 6: 189–196.[CrossRef][Medline] [Order article via Infotrieve]
43. Han H, Fuortes M, Nathan C. Critical role of the carboxyl terminus of proline-rich tyrosine kinase (Pyk2) in the activation of human neutrophils by tumor necrosis factor: separation of signals for the respiratory burst and degranulation. J Exp Med. 2003; 197: 63–75.
44. Zhao T, Bokoch GM. Critical role of proline-rich tyrosine kinase 2 in reversion of the adhesion-mediated suppression of reactive oxygen species generation by human neutrophils. J Immunol. 2005; 174: 8049–8055.
45. Pleiman CM, Clark MR, Gauen LK, Winitz S, Coggeshall KM, Johnson GL, Shaw AS, Cambier JC. Mapping of sites on the Src family protein tyrosine kinases p55blk, p59fyn, and p56lyn which interact with the effector molecules phospholipase C-gamma 2, microtubule-associated protein kinase, GTPase-activating protein, and phosphatidylinositol 3-kinase. Mol Cell Biol. 1993; 13: 5877–5887.
46. Kapeller R, Prasad KV, Janssen O, Hou W, Schaffhausen BS, Rudd CE, Cantley LC. Identification of two SH3-binding motifs in the regulatory subunit of phosphatidylinositol 3-kinase. J Biol Chem. 1994; 269: 1927–1933.
47. Atochin DN, Wang A, Liu VW, Critchlow JD, Dantas AP, Looft-Wilson R, Murata T, Salomone S, Shin HK, Ayata C, Moskowitz MA, Michel T, Sessa WC, Huang PL. The phosphorylation state of eNOS modulates vascular reactivity and outcome of cerebral ischemia in vivo. J Clin Invest. 2007; 117: 1961–1967.[CrossRef][Medline] [Order article via Infotrieve]
48. Chen CA, Druhan LJ, Varadharaj S, Chen YR, Zweier JL. Phosphorylation of endothelial nitric oxide synthase (eNOS) regulates superoxide generation from the enzyme. J Biol Chem. 2008; 283: 27038–27047.
This article has been cited by other articles:
 |
|
 |
|
  P. W. Sanders Dietary Salt Intake, Salt Sensitivity, and Cardiovascular Health Hypertension, March 1, 2009; 53(3): 442 - 445. [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||